Horizon Therapeutics Public Ltd Co

FMR LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

205,419

Value ($000)

23,765

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	23,765	0.0%	205,419	9/30/2023
2023 Q2	8/11/2023	20,006	0.0%	194,520	6/30/2023
2023 Q1	5/11/2023	19,102	0.0%	175,023	3/31/2023
2022 Q4	2/13/2023	17,856	0.0%	156,906	12/31/2022
2022 Q3	11/10/2022	106,979	0.0%	1,728,554	9/30/2022
2022 Q2	8/12/2022	966,182	0.1%	12,113,619	6/30/2022
2022 Q1	5/13/2022	1,593,673	0.1%	15,147,543	3/31/2022
2021 Q4	2/14/2022	1,710,265	0.1%	15,871,042	12/31/2021
2021 Q3	2/14/2022	1,709,314	0.1%	15,604,482	9/30/2021
2021 Q2	8/13/2021	1,387,281	0.1%	14,815,051	6/30/2021
2021 Q1	5/14/2021	1,283,037	0.1%	13,939,994	3/31/2021
2020 Q4	2/8/2021	969,490	0.1%	13,253,442	12/31/2020
2020 Q3	11/13/2020	1,272,454	0.1%	16,380,717	9/30/2020
2020 Q2	8/24/2020	405,093	0.0%	7,288,468	6/30/2020
2020 Q1	5/14/2020	176,859	0.0%	5,970,913	3/31/2020
2019 Q4	2/7/2020	236,834	0.0%	6,542,361	12/31/2019